Promoter methylation correlates with reduced NDRG2 expression in advanced colon tumour

BMC Medical Genomics

Volumn 2, Issue , 2009, Pages

  Piepoli, Ada ^a   Cotugno, Rosa ^a   Merla, Giuseppe ^a   Gentile, Annamaria ^a   Augello, Bartolomeo ^a   Quitadamo, Michele ^a   Merla, Antonio ^a   Panza, Anna ^a   Carella, Massimo ^a   Maglietta, Rosalia ^b   D'Addabbo, Annarita ^b   Ancona, Nicola ^b   Fusilli, Saverio ^a   Perri, Francesco ^a   Andriulli, Angelo ^a  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b INSTITUTE OF INTELLIGENT SYSTEMS FOR AUTOMATION   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXYPROSTAGLANDIN DEHYDROGENASE; 5 AZA 2' DEOXYCYTIDINE; ABC TRANSPORTER; ABC TRANSPORTER A1; ACTIN BINDING PROTEIN; AQUAPORIN 8; CARRIER PROTEIN; CELL NUCLEUS RECEPTOR; CHLORIDE CHANNEL; CYCLIN B1; HEAT SHOCK PROTEIN; INSULIN RECEPTOR; PEROXIDASE; PRESTIN; REPLICATION FACTOR C; RNA; SERUM AND GLUCOCORTICOID REGULATED KINASE 1; SODIUM CHANNEL; SODIUM CHLORIDE COTRANSPORTER; SYNTAXIN; TESTIS DETERMINING FACTOR;

ADULT; ARTICLE; C MYB DOWNSTREAM REGULATED GENE 2; CANCER CELL CULTURE; CANCER STAGING; CELL STRAIN CACO 2; CELL STRAIN HCT116; COLORECTAL CANCER; CONTROLLED STUDY; DNA METHYLATION; DNA MICROARRAY; FEMALE; GENE; GENE EXPRESSION; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 63349087532     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-2-11     Document Type: Article

References (39)

1. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. AB Benson D Schrag MR Somerfield AM Cohen AT Figueredo PJ Flynn MK Krzyzanowska J Maroun P McAllister E Van Cutsem, J Clin Oncol 2004 22 3408 3419 15199089
2. Genetic alterations during colorectal-tumor development. B Vogelstein ER Fearon SR Hamilton SE Kern AC Preisinger M Leppert Y Nakamura R White AM Smits JL Bos, N Engl J Med 1988 319 525 532 2841597
3. The genetic basis of colorectal cancer: insights into critical pathways of tumorigenesis. DC Chung, Gastroenterology 2000 119 854 865 10982779
4. Self-renewal and cancer of the gut: two sides of a coin. F Radtke H Clevers, Science 2005 307 1904 1909 15790842
5. Oncogenic K-RAS is required to maintain changes in cytoskeletal organization, adhesion, and motility in colon cancer cells. CB Pollock S Shirasawa T Sasazuki W Kolch AS Dhillon, Cancer Res 2005 65 1244 1250 15735008
6. Cancer epigenetics comes of age. PA Jones PW Laird, Nat Genet 1999 21 163 167 9988266
7. Relevance of DNA methylation in the management of cancer. M Esteller, Lancet Oncol 2003 4 351 358 12788407
8. Quantitative DNA methylation analysis in human neoplastic disease. WB Coleman AG Rivenbark, J Mol Diagn 2006 8 152 156 16645200
9. Hypomethylattion of ras oncogenes in primary human cancer. AP Feinberg B Vogelstein, Biochem Biophys Res Commun 1983 111 47 54 6187346
10. Hypomethylation of L1 retrotransposons in colorectal cancer and adjacent normal tissue. CM Suter DI Martin RL Ward, Int J Colorectal Dis 2004 19 95 101 14534800
11. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. SB Baylin JG Herman, Trends Genet 2000 16 168 174 10729832
12. Gene silencing in cancer in association with promoter hypermethylation. JG Herman SB Baylin, N Engl J Med 2003 349 2042 2054 14627790
13. The history of cancer epigenetics. AP Feinberg B Tycko, Nat Rev Cancer 2004 4 143 153 14732866
14. On the statistical assessment of classifiers using DNA microarray data. N Ancona R Maglietta A Piepoli A D'Addabbo R Cotugno M Savino S Liuni M Carella G Pesole F Perri, BMC Bioinformatics 2006 7 387 16919171
15. Aberrant methylation of the HPP1 gene in ulcerative colitis-associated colorectal carcinoma. F Sato D Shibata N Harpaz Y Xu J Yin Y Mori S Wang A Olaru E Deacu FM Selaru, Cancer Res 2002 62 6820 6822 12460892
16. Roles of cell division and gene transcription in the methylation of CpG islands. CM Bender ML Gonzalgo FA Gonzales CT Nguyen KD Robertson PA Jones, Mol Cell Biol 1999 19 6690 6698 10490608
17. Identification of silencing of nine genes in human gastric cancers. A Kaneda M Kaminishi K Yanagihara T Sugimura T Ushijima, Cancer Res 2002 62 6645 6650 12438262
18. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. JG Herman JR Graff S Myohanen BD Nelkin SB Baylin, Proc Natl Acad Sci 1996 93 9821 9826 8790415
19. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. KJ Livak TD Schmittgen, Methods 2001 25 402 408 11846609
20. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. J Vandesompele K De Preter F Pattyn B Poppe N Van Roy A De Paepe F Speleman, Genome Biol 2002 3 research 0034.1 0034.11
21. Biostatistics: A Methodology for the Health Sciences. Author(s) of Review: Stephan M. Rudolfer Journal of the Royal Statistical Society. LD Fisher G van Belle, Series A (Statistics in Society) 1994 157 2 306 307
22. Mechanisms of mineralocorticoid action. PJ Fuller MJ Young, Hypertension 2005 6 1227 1235
23. Modulation of the Ca(2+)-activated Cl(-) channel by 14-3-3epsilon. HC Chan WL Wu SC So YW Chung LL Tsang XF Wang YC Yan SC Luk SS Siu SK Tsui, Biochem Biophys Res Commun 2000 270 581 587 10753667
24. The role of parental and grandparental epigenetic alterations in familial cancer risk. JL Fleming TH Huang AE Toland, Cancer Res 2008 68 9116 9121 Review 19010880
25. The necessity of a human epigenome project. M Esteller, Carcinogenesis 2006 27 1121 1125 16699174
26. Epigenetic gene regulation: linking early developmental environment to adult disease. DC Dolinoy JR Weidman RL Jirtle, Reprod Toxicol 2000 23 297 307
27. Alterations in DNA methylation: a fundamental aspect of neoplasia. SB Baylin JG Herman JR Graff PM Vertino JP Issa, Adv Cancer Res 1998 72 141 196 Review 9338076
28. Gene expression levels assessed by oligonucleotide microarray analysis and quantitative real-time RT-PCR - how well do they correlate? PB Dallas NG Gottardo MJ Firth AH Beesley K Hoffmann PA Terry JR Freitas JM Boag AJ Cummings UR Kees, BMC Genomics 2005 6 59 15854232
29. Loss-of-function of Nkx3.1 promotes increased oxidative damage in prostate carcinogenesis. X Ouyang TL DeWeese WG Nelson C Abate-Shen, Cancer Res 2005 65 6773 6779 16061659
30. N-Myc downstream-regulated gene 2 (NDRG2) inhibits glioblastoma cell proliferation. Y Deng L Yao L Chau SS Ng Y Peng X Liu WS Au J Wang F Li S Ji, Int J Cancer 2003 106 342 347 12845671
31. Expression and regulation of NDRG2 (N-myc downstream regulated gene 2) during the differentiation of dendritic cells. SC Choi KD Kim JT Kim JW Kim DY Yoon YK Choe YS Chang SG Paik JS Lim, FEBS Lett 2003 553 413 418 14572661
32. Characterization of the human NDRG gene family: a newly identified member, NDRG4, is specifically expressed in brain and heart. RH Zhou K Kokame Y Tsukamoto C Yutani H Kato T Miyata, Genomics 2001 73 86 89 11352569
33. Characterization and expression of three novel differentiation-related genes belong to the human NDRG gene family. X Qu Y Zhai H Wei C Zhang G Xing Y Yu F He, Mol Cell Biochem 2002 229 35 44 11936845
34. Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma. EA Lusis MA Watson MR Chicoine M Lyman P Roerig G Reifenberger DH Gutmann A Perry, Cancer Res 2005 65 7121 7126 16103061
35. Promoter methylation, mutation, and genomic deletion are involved in the decreased NDRG2 expression levels in several cancer cell lines. N Liu L Wang X Liu Q Yang J Zhang W Zhang Y Wu L Shen Y Zhang A Yang, Biochem Biophys Res Commun 2007 358 64 169
36. Akt mediates insulin-stimulated phosphorylation of Ndrg2: evidence for cross-talk with protein kinase C theta. JG Burchfield AJ Lennard S Narasimhan WE Hughes VC Wasinger GL Corthals T Okuda H Kondoh TJ Biden C Schmitz-Peiffer, J Biol Chem 2004 279 18623 18632 14985363
37. NDRG2 expression and mutation in human liver and pancreatic cancers. XL Hu XP Liu SX Lin YC Deng N Liu X Li LB Yao, World J Gastroenterol 2004 10 3518 3521 15526377
38. The repression of human differentiation-related gene NDRG2 expression by Myc via Miz-1-dependent interaction with the NDRG2 core promoter. J Zhang F Li X Liu L Shen J Liu J Su W Zhang Y Deng L Wang N Liu, J Biol Chem 2006 281 39159 39168 17050536
39. Expression of NDRG2 is down-regulated in high-risk adenomas and colorectal carcinoma. A Lorentzen LK Vogel RH Lewinsky M Saebø CF Skjelbred S Godiksen G Hoff KM Tveit IM Lothe T Ikdahl, BMC Cancer 2007 7 192 17935612